The Future Of Small And Large Molecule Bioanalytics Today

By Troy Voelker, Lab Director, Pyxant Labs, and Shane Karnik, Senior Laboratory Director, Pyxant Labs

Over the past 50 years of drug development, traditional mass spectrometry and liquid chromatography have served as the foundation of bioanalytical techniques for small molecules, whereas ligand binding assays have served as the foundation for large molecules. New analytical techniques have emerged to make it easier to analyze larger and more complex compounds as biological therapies grow more widespread.

To truly understand the way these novel therapies function in living biological systems, however, a new dimension of study will be indispensable: spatial bioanalysis. Discover how this analytic technique can provide answers regarding molecule function and form that—together with other state-of-the-art analytics— can improve the quantity and quality of information obtainable in drug development studies.